Report Detail
Global (United States, European Union and China) Pneumococcal Polysaccharide Vaccine Market Research Report 2019-2025
- RnM3663749 |
- 13 August, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Pneumococcal disease is an infection caused by the Streptococcus pneumoniae bacteria, which especially affects infants and children below 5 years of age.
The major factors that contribute to the growth of the pneumococcal polysaccharide vaccine market include increasing prevalence of pneumonia globally, improving healthcare infrastructure, rise in government focus on immunization programs for pneumonia, and development of quality vaccines such as PPSV23.
In 2019, the market size of Pneumococcal Polysaccharide Vaccine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Pneumococcal Polysaccharide Vaccine.
This report studies the global market size of Pneumococcal Polysaccharide Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Pneumococcal Polysaccharide Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Merck & Co., Inc.
Pfizer Inc.
Glaxosmithkline Plc.
Sanofi Pasteur
China National Biotec Group
Astellas Pharma Inc
Serum Institute of India Pvt. Ltd
...
Market Segment by Product Type
Single Dose Vial
Pre-Filled Syringe
Market Segment by Application
Children (2-10 Age)
Adult (10-64 Age)
Geriatric (More Than 65 Age)
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Pneumococcal Polysaccharide Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Pneumococcal Polysaccharide Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Pneumococcal Polysaccharide Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Single Dose Vial
- 1.3.3 Pre-Filled Syringe
- 1.4 Market Segment by Application
- 1.4.1 Global Pneumococcal Polysaccharide Vaccine Market Share by Application (2019-2025)
- 1.4.2 Children (2-10 Age)
- 1.4.3 Adult (10-64 Age)
- 1.4.4 Geriatric (More Than 65 Age)
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Pneumococcal Polysaccharide Vaccine Market Size
- 2.1.1 Global Pneumococcal Polysaccharide Vaccine Revenue 2014-2025
- 2.1.2 Global Pneumococcal Polysaccharide Vaccine Sales 2014-2025
- 2.2 Pneumococcal Polysaccharide Vaccine Growth Rate by Regions
- 2.2.1 Global Pneumococcal Polysaccharide Vaccine Sales by Regions 2014-2019
- 2.2.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Pneumococcal Polysaccharide Vaccine Sales by Manufacturers
- 3.1.1 Pneumococcal Polysaccharide Vaccine Sales by Manufacturers 2014-2019
- 3.1.2 Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Pneumococcal Polysaccharide Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.3 Pneumococcal Polysaccharide Vaccine Price by Manufacturers
- 3.4 Key Manufacturers Pneumococcal Polysaccharide Vaccine Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Pneumococcal Polysaccharide Vaccine Market
- 3.6 Key Manufacturers Pneumococcal Polysaccharide Vaccine Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Single Dose Vial Sales and Revenue (2014-2019)
- 4.1.2 Pre-Filled Syringe Sales and Revenue (2014-2019)
- 4.2 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type
- 4.3 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type
- 4.4 Pneumococcal Polysaccharide Vaccine Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Pneumococcal Polysaccharide Vaccine Sales by Application
6 United States
- 6.1 United States Pneumococcal Polysaccharide Vaccine Breakdown Data by Company
- 6.2 United States Pneumococcal Polysaccharide Vaccine Breakdown Data by Type
- 6.3 United States Pneumococcal Polysaccharide Vaccine Breakdown Data by Application
7 European Union
- 7.1 European Union Pneumococcal Polysaccharide Vaccine Breakdown Data by Company
- 7.2 European Union Pneumococcal Polysaccharide Vaccine Breakdown Data by Type
- 7.3 European Union Pneumococcal Polysaccharide Vaccine Breakdown Data by Application
8 China
- 8.1 China Pneumococcal Polysaccharide Vaccine Breakdown Data by Company
- 8.2 China Pneumococcal Polysaccharide Vaccine Breakdown Data by Type
- 8.3 China Pneumococcal Polysaccharide Vaccine Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Pneumococcal Polysaccharide Vaccine Breakdown Data by Company
- 9.2 Rest of World Pneumococcal Polysaccharide Vaccine Breakdown Data by Type
- 9.3 Rest of World Pneumococcal Polysaccharide Vaccine Breakdown Data by Application
- 9.4 Rest of World Pneumococcal Polysaccharide Vaccine Breakdown Data by Countries
- 9.4.1 Rest of World Pneumococcal Polysaccharide Vaccine Sales by Countries
- 9.4.2 Rest of World Pneumococcal Polysaccharide Vaccine Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Merck & Co., Inc.
- 10.1.1 Merck & Co., Inc. Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Pneumococcal Polysaccharide Vaccine
- 10.1.4 Pneumococcal Polysaccharide Vaccine Product Introduction
- 10.1.5 Merck & Co., Inc. Recent Development
- 10.2 Pfizer Inc.
- 10.2.1 Pfizer Inc. Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Pneumococcal Polysaccharide Vaccine
- 10.2.4 Pneumococcal Polysaccharide Vaccine Product Introduction
- 10.2.5 Pfizer Inc. Recent Development
- 10.3 Glaxosmithkline Plc.
- 10.3.1 Glaxosmithkline Plc. Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Pneumococcal Polysaccharide Vaccine
- 10.3.4 Pneumococcal Polysaccharide Vaccine Product Introduction
- 10.3.5 Glaxosmithkline Plc. Recent Development
- 10.4 Sanofi Pasteur
- 10.4.1 Sanofi Pasteur Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Pneumococcal Polysaccharide Vaccine
- 10.4.4 Pneumococcal Polysaccharide Vaccine Product Introduction
- 10.4.5 Sanofi Pasteur Recent Development
- 10.5 China National Biotec Group
- 10.5.1 China National Biotec Group Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Pneumococcal Polysaccharide Vaccine
- 10.5.4 Pneumococcal Polysaccharide Vaccine Product Introduction
- 10.5.5 China National Biotec Group Recent Development
- 10.6 Astellas Pharma Inc
- 10.6.1 Astellas Pharma Inc Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Pneumococcal Polysaccharide Vaccine
- 10.6.4 Pneumococcal Polysaccharide Vaccine Product Introduction
- 10.6.5 Astellas Pharma Inc Recent Development
- 10.7 Serum Institute of India Pvt. Ltd
- 10.7.1 Serum Institute of India Pvt. Ltd Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Pneumococcal Polysaccharide Vaccine
- 10.7.4 Pneumococcal Polysaccharide Vaccine Product Introduction
- 10.7.5 Serum Institute of India Pvt. Ltd Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Pneumococcal Polysaccharide Vaccine Sales Channels
- 11.2.2 Pneumococcal Polysaccharide Vaccine Distributors
- 11.3 Pneumococcal Polysaccharide Vaccine Customers
12 Market Forecast
- 12.1 Global Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast 2019-2025
- 12.2 Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Type
- 12.3 Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Application
- 12.4 Pneumococcal Polysaccharide Vaccine Forecast by Regions
- 12.4.1 Global Pneumococcal Polysaccharide Vaccine Sales Forecast by Regions 2019-2025
- 12.4.2 Global Pneumococcal Polysaccharide Vaccine Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Pneumococcal Polysaccharide Vaccine. Industry analysis & Market Report on Pneumococcal Polysaccharide Vaccine is a syndicated market report, published as Global (United States, European Union and China) Pneumococcal Polysaccharide Vaccine Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Pneumococcal Polysaccharide Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
